Delivery Order SPE2DB22D3019-SPE2DB25FK3BH
Award Date
1/30/25
Potential Completion Date
1/31/25
Potential Value
$9.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,933.91 firm fixed price contract is for the delivery of VERQUVO 2.5 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of October 21, 2024 and is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,854.78 contract is for the supply of VERQUVO 5 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of June 10, 2024 and was issued on June 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a value of $1,039.56 and a period of performance through January 17, 2025. It is a firm fixed-price contract for the supply of VERQUVO 5 MG TABLET 30S, a pharmaceutical product. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and no subcontractors are mentioned. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,705.63, is for the delivery of the drug VERQUVO 10 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 28, 2024. The contract was awarded on October 25, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization,...
The federal contract award summarized in the provided information is for the delivery of VERQUVO 2.5 MG TABLET 30S pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor for this $28,684.71 firm fixed price delivery order contract is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024, with no set-aside requirements....
This federal contract award, valued at $1,087.74, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of the pharmaceutical product VERQUVO 5 MG TABLET 30S. The contract has a firm fixed price of $2,729.58 and an ultimate completion date of August 2, 2024. No set-aside designation was used for this award. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $11,921.19 firm-fixed-price contract is for the delivery of the medication VERQUVO 10 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order worth $3,041.52 by the Defense Logistics Agency (DLA) to provide VERQUVO 10 MG TABLET 30S, a pharmaceutical product, with a completion date of February 7, 2024. This order falls under Amerisourcebergen's existing indefinite delivery contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for...
This federal contract award, with ID SPE2DB22D3102|SPE2DB25FK9LT, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,079.12 firm fixed-price delivery order is for the supply of 4566873886 VERQUVO 5 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of January 9, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...